REFERENCES
- Krumpaszky, HG, Klauss V. Time trends of causes of blindness. Klinische Monatsblatter Fur Augenheilkunde 1997;210(2):Aa9–Aa16.
- Schmidt U, Murken J, Klauss V. [Change in the course of blindness in childhood]. Klin Monbl Augenheilkd 1988;193(5):457–464.
- Resnikoff S, Pascolini D, Etya’ale D. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82(11):844–851.
- West S, Sommer A. Prevention of blindness and priorities for the future. Bull World Health Organ 2001;79(3):244–248.
- Backlund LB, Algvere PV, Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 1997;14(9):732–740.
- Horle S, Gruner F, Kroll P. [Epidemiology of diabetes-induced blindness − a review]. Klin Monbl Augenheilkd 2002;219(11):777–784.
- Trautner C, Haastert B, Giani G. Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia 2001;44(2):147–150.
- Genz J, et al. Reduced incidence of blindness in relation to diabetes mellitus in southern Germany? Diabet Med 2010;27(10):1138–1143.
- Bodeau-Livinec F, et al. Recent trends in visual impairment and blindness in the UK. Arch Dis Child 2007;92(12):1099–1104.
- Rowlands E, et al. Reduced incidence of retinopathy of prematurity. Br J Ophthalmol 2001;85(8):933–935.
- Congdon N, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122(4):477–485.
- Knauer C, Pfeiffer N. Blindness in Germany − today and in 2030. Ophthalmologe 2006;103(9):735–741.
- Lee DJ, et al. Trends in visual acuity impairment in US adults: the 1986-1995 National Health Interview Survey. Arch Ophthalmol 2004;122(4):506–509.
- Rohrschneider K, Greim S. Epidemiology of blindness in Baden, Germany. Klinische Monatsblatter Fur Augenheilkunde 2004;221(2):116–121.
- Bertram B. Blindness and visual impairment in Germany: causes and Frequencies [Blindheit und Sehbehinderung in Deutschland: Ursachen und Häufigkeiten]. Der Augenarzt 2005;39(6):267–271.
- Brezin AP, et al. Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community: a nationwide survey. Arch Ophthalmol 2005;123(8):1117–1124.
- Klaver CC, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116(5):653–658.
- Buch H, et al. The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. Acta Ophthalmol Scand 2001;79(5):441–449.
- Krumpaszky HG, et al. [New blindness incidents in Wurttemberg-Hohenzollern]. Ophthalmologe 1997;94(3):234–236.
- Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999–March 2000. Eye (Lond) 2008;22(7):905–911.
- Farber MD. National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness. Ophthalmic Epidemiol 2003;10(4):267–277.
- Finger RP. Blindness in Germany: dimensions and perspectives. Ophthalmologe 2007;104(10):839–844.
- Yong VK, et al. Trends in registered blindness and its causes over 19 years in Western Australia. Ophthalmic Epidemiol 2006;13(1):35–42.
- Taylor HR, et al. Vision loss in Australia. Med J Aust 2005;182(11):565–568.
- Yamada M, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol 2010;17(1):50–57.
- Lafuma A, et al. Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK. Pharmacoeconomics 2006;24(2):193–205.
- Muller A. [Visual impairment − implications on health, costs and predictions for the future]. Klin Monbl Augenheilkd 2005;222(1):32–35.